Form D · Biotechnology
Bionano Genomics, Inc.
San Diego, CA · CIK 0001411690
Offering snapshot reported Jul 10, 2024 · SEC filing
- Reported sold
- $20M Offering amount: $20M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 8, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 10, 2024 | Initial | $20,000,001 | No comparison | 2 | SEC filing |
| Jun 5, 2024 | Initial | $20,000,000 | No comparison | 4 | SEC filing |
| Oct 27, 2023 | Initial | $35,000,000 | No comparison | 1 | SEC filing |
| Oct 25, 2021 | Initial | $41,850,386 | No comparison | 27 | SEC filing |
| Mar 28, 2019 | Initial | $2,500,000 | No comparison | 3 | SEC filing |
| Jan 27, 2015 | Initial | $68,443,451 | No comparison | 17 | SEC filing |
| Jun 27, 2014 | Initial | $5,000,500 | No comparison | 5 | SEC filing |
| Jan 8, 2014 | Initial | $15,000 | No comparison | 1 | SEC filing |
| Oct 2, 2013 | Initial | $10,001,000 | No comparison | 5 | SEC filing |
| Jul 5, 2012 | Initial | $11,573,201 | No comparison | 6 | SEC filing |
| Mar 24, 2011 | Initial | $23,265,909 | No comparison | 9 | SEC filing |
| Apr 27, 2010 | Initial | $782,314 | No comparison | 3 | SEC filing |
| Oct 3, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 31, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $400K
- Finders' fees
- $0
- Form D file number
- 021-518329
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| H.C. Wainwright & Co., LLC | 375 |
Source: Form D, filed Jul 10, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David L. Barker | Director |
| David L. Barker, Ph.D. | Director |
| Mark Borodkin | Executive |
| Darren Cai | Director |
| Darren Cai, Ph.D. | Director |
| Han Cao | Executive |
| Alka Chaubey | Executive |
| Alka Chaubey, Ph.D., Facmg | Executive |
| Jonathan Dixon | Executive |
| Edward L. Erickson | Director, Executive |
| Brian Halak | Director |
| R. Erik Holmlin | Director, Executive |
| Robert Erik Holmlin | Director, Executive |
| Erik R. Holmlin | Director, Executive |
| R. Erik Holmlin, Ph.D. | Director, Executive |
| Joel Jung | Executive |
| Gulsen Kama | Executive |
| Yvonne Linney | Director |
| Yvonne Linney, Ph.D. | Director |
| Lorraine G. Lo Presti | Executive |
| Albert A. Luderer | Director |
| Albert A. Luderer, Ph.D. | Director |
| Hannah Mamuszka | Director |
| Garth Monroe | Executive |
| Campbell Murray | Director |
| Mark Oldakowski | Executive |
| Jason Priar | Executive |
| Aleksandar Rajkovic | Director |
| Aleksandar Rajkovic, M.D., Ph.D. | Director |
| Warren Robinson | Executive |
| Lynne Rollins | Executive |
| Soheil Shams | Executive |
| Richard Shippy | Executive |
| Christopher Stewart | Executive |
| Christopher Twomey | Director |
| Kristiina Vuori | Director |
| Kristiina Vuori, M.D., Ph.D. | Director |
| Junfeng Wang | Director |
| Mike Ward | Executive |
| Tracy Warren | Director |
| Vincent Wong | Director |
| Vincent Wong, J.D., M.B.A. | Director |
| Quan Zhou | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9540 Towne Centre Drive Suite 100
San Diego, CA, 92121
San Diego, CA, 92121